Myriam Curet Nektar Therapeutics (NKTR) insider trading activity
Myriam Curet is Director of NEKTAR THERAPEUTICS. Currently has a direct ownership of 27,418 shares of NKTR, which is worth approximately $32,627. The most recent transaction as insider was on Sep 18, 2023, when has been sold 4,359 shares (Common Stock) at a price of $0.69 per share, resulting in proceeds of $3,007. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
27.4K
0%
3M change
0%
12M change
Total Value Held
$32,627
Myriam Curet Transaction History
Also insider at
MC
Myriam Curet
Director
Sunnyvale, CA